LCS3
LCS3 is a reversible and non-competitive synergistic inhibitor of glutathione disulfide reductase (GSR) and thioredoxin reductase 1 (TXNRD1) with IC50s of 3.3 μM and 3.8 μM, respectively. LCS3 has antitumour activity, induces apoptosis and can be used in the study of lung adenocarcinoma (LUAD) .
Product Specifications
CAS Number
109844-92-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
266.64
Molecular Formula
C11H7ClN2O4
Notes
Research use only, not for human use.
Receptor
Apoptosis | Glutathione reductase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1333958-01 0.02 mg (E-Coli)
Recombinant Bradyrhizobium japonicum Probable rRNA maturation factor (bll0793)
Sign In for Pricing
View Details MBS1333958-02 0.1 mg (E-Coli)
Recombinant Bradyrhizobium japonicum Probable rRNA maturation factor (bll0793)
Sign In for Pricing
View Details MBS1333958-03 0.02 mg (Yeast)
Recombinant Bradyrhizobium japonicum Probable rRNA maturation factor (bll0793)
Sign In for Pricing
View Details MBS1333958-04 0.1 mg (Yeast)
Recombinant Bradyrhizobium japonicum Probable rRNA maturation factor (bll0793)
Sign In for Pricing
View Details MBS1333958-05 0.02 mg (Baculovirus)
Recombinant Bradyrhizobium japonicum Probable rRNA maturation factor (bll0793)
Sign In for Pricing
View Details MBS1333958-06 0.02 mg (Mammalian-Cell)
Recombinant Bradyrhizobium japonicum Probable rRNA maturation factor (bll0793)
Sign In for Pricing
View Details